6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings have informed clinical practice guidelines and policy, which now recommend that SMBG not be used routinely in this group (21–26).”
In the citing paper
“While the drug manufacturer is currently offering a savings card program for some patients for whom pricing is a barrier, payor coverage for tirzepatide will likely be a barrier to patient use, especially before tirzepatide has been officially recognized as a standard of care in professional guidelines. 2”
From Tirzepatide: Clinical review of the twincretin injectable (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 2×
“33% with metformin as initial pharmacotherapy) and in all-cause mortality (13% and 27%, respectively) (33).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Research works printed but not linked: 1
- Dicembrini, Impact of technology on glycemic control in type 2 diabetes: a meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion, Diabetes Obes Metab
Cited by
Items 101–200 of 846
Benhamou, P., Adenis, A., Lebbad, H., Tourki, Y., Heredia, M., Gehr, B., Franc, S., & Charpentier, G. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15008 · Cited by 35
Formichi, C., Fignani, D., Nigi, L., Grieco, G. E., Brusco, N., Licata, G., Sabato, C., Ferretti, E., Sebastiani, G., & Dotta, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179454 · Cited by 38
Holland, D., Heald, A. H., Stedman, M., Hanna, F., Wu, P., Duff, C. J., Green, L., Robinson, S., Halsall, I., Gaskell, N., et al. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207776 · Cited by 34
Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes
Rodríguez‐Gutiérrez, R., Millán-Alanís, J. M., Barrera, F. J., & McCoy, R. G. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01433-0 · Cited by 38
Managing Patients Undergoing Orthopedic Surgery to Improve Glycemic Outcomes
Díaz, R. S., & DeJesus, J. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01434-z · Cited by 36
Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkuś, J., & Pyrzyńska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642166 · Cited by 41
Rahiotis, C., Petraki, V., & Mitrou, P. (2021) · Journal of Dentistry · doi:10.1016/j.jdent.2021.103629 · Cited by 41
Shin, J., Wang, D., Fernandes, G. F., Daya, N. R., Grams, M. E., Golden, S. H., Rajpathak, S. N., & Selvin, E. (2021) · Diabetes Care · doi:10.2337/dc20-2541 · Cited by 34
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients
Brodosi, L., Petta, S., Petroni, M. L., Marchesini, G., & Morelli, M. C. (2021) · Transplantation · doi:10.1097/tp.0000000000003867 · Cited by 36
Albanese-O’Neill, A., Grimsmann, J. M., Svensson, A., Miller, K. M., Raile, K., Åkesson, K., Calhoun, P. M., Biesenbach, B., Eeg‐Olofsson, K., Holl, R. W., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0225 · Cited by 32
Edward, J. A., Josey, K., Bahn, G., Caplan, L., Reusch, J. E. B., Reaven, P. D., Ghosh, D., & Raghavan, S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01496-7 · Cited by 33
Cherney, D. Z. I., Hadjadj, S., Lawson, J., Mosenzon, O., Tuttle, K. R., Vrhnjak, B., Rasmussen, S., & Bain, S. C. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.07.167 · Cited by 34
Silva, R. R. E., Gauza, M. D. M., Guisso, M. E. S., da Silva, J. O. N., & Kohara, S. K. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000614 · Cited by 33
“We included Icodec titration B in our analysis, since this group used a 28 unit/week adjustment and a prebreakfast target of 80-130 mg/ dL which aligns with ADA recommendations (17).”
MethodXie, P., Deng, B., Zhang, X., Li, Y., Du, C., Rui, S., Deng, W., Boey, J., Armstrong, D. G., Ma, Y., et al. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3498 · Cited by 33
“The methods used to calculate the above‐mentioned glycaemic metrics were line with the standardised CGM metrics for clinical care.(21) CV for each patient was defined as the standard deviation of glucose measurements divided by MBG during the hospitalisation period.”
MethodYuan, X., Guo, X., Zhang, J., Dong, X., Lu, Y., Pang, W., Gu, S., Niemoeller, E., Lin, P., Nian, G., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14803 · Cited by 31
Alho, I., Lappalainen, P., Muotka, J., & Lappalainen, R. (2022) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2022.08.002 · Cited by 27
The Effect of Diabetes and Metabolic Syndrome on Spine Surgery Outcomes
Bajaj, A., Shah, R. M., Brecount, H. J., Kurapaty, S. S., Patel, A. A., & Divi, S. N. (2022) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-022-09814-y · Cited by 28
Zhang, J., Yang, J., Liu, L., Li, L., Cui, J., Wu, S., & Tang, K. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00753-2 · Cited by 32
Glucagon: Its evolving role in the management of hypoglycemia
Isaacs, D. M., Clements, J. N., Turco, N., & Hartman, R. (2021) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2534 · Cited by 31
Bexagliflozin for type 2 diabetes: an overview of the data
Azzam, O., Carnagarin, R., Lugo‐Gavidia, L. M., Nolde, J. M., Matthews, V. B., & Schlaich, M. P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1959915 · Cited by 31
Lauritzen, E. S., Kampmann, U., Smedegaard, S. B., & Støy, J. (2021) · Clinical Endocrinology · doi:10.1111/cen.14576 · Cited by 29
Pan, J., Xu, Y., Chen, S., Tu, Y., Mo, Y., Gao, F., Zhou, J., Hu, C., & Jia, W. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6303063 · Cited by 36
“0 mmol/L is a useful parameter to evaluate the treatment regimen [17].”
BackgroundMcCrimmon, R. J., Sifri, S. A., Emral, R., Mohan, V., Sauque‐Reyna, L., Trescolí, C., Lalic, N. M., Alvarez, A., Demil, N., Coudert, M., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14354 · Cited by 31
Glucagon use by U.S. adults with type 1 and type 2 diabetes
Kahn, P. A., Liu, S., McCoy, R., Gabbay, R. A., & Lipska, K. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107882 · Cited by 27
Sinha, B., & Ghosal, S. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01062-6 · Cited by 34
Lam, D. W.-H., & Shaikh, A. (2021) · Kidney360 · doi:10.34067/kid.0000412021 · Cited by 30
Continuous glucose monitoring in persons with type 2 diabetes not using insulin
Cowart, K., Updike, W. H., & Franks, R. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.1992274 · Cited by 27
Reid, L. A., Mendoza, J. A., Merchant, A. T., Geraci, M., Reboussin, B. A., Malik, F. S., Ellyson, A. M., Dabelea, D., Merjaneh, L., Marcovina, S. M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13386 · Cited by 24
Wang, Y., Lu, J., Ni, J., Wang, M., Shen, Y., Lu, W., Zhu, W., Bao, Y., Rodbard, D., Vigersky, R. A., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15068 · Cited by 33
Understanding temporal changes and seasonal variations in glycemic trends using wearable data
Belsare, P. V., Bartolome, A., Stanger, C., & Prioleau, T. (2023) · Science Advances · doi:10.1126/sciadv.adg2132 · Cited by 31
Piechocki, M., Przewłocki, T., Pieniążek, P., Trystuła, M., Podolec, J., & Kabłak-Ziembicka, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051508 · Cited by 34
“The American Diabetes Association 2021 guidelines suggest a goal hemoglobin A1c of 7.0% for most patients with type 2 diabetes without significant hypoglycemia [147].”
BackgroundInfluentialSecher, A. L., Pedersen‐Bjergaard, U., Svendsen, O. L., Gade-Rasmussen, B., Almdal, T., RAIMOND, L. H., Vistisen, D., & Nørgaard, K. (2021) · Diabetologia · doi:10.1007/s00125-021-05555-8 · Cited by 29
Tanenbaum, M. L., Messer, L. H., Wu, C., Basina, M., Buckingham, B. A., Hessler, D., Mulvaney, S. A., Maahs, D. M., & Hood, K. K. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109048 · Cited by 29
Aberer, F., Moser, O., Aziz, F., Sourij, C., Ziko, H., Lenz, J., Abbas, F., Obermayer, A. M., Kojzar, H., Pferschy, P. N., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1563 · Cited by 26
Alshammari, N. A., Alodhayani, A. A., Joy, S. S., Isnani, A. C., Mujammami, M. H., Alfadda, A. A., & Siddiqui, K. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s364933 · Cited by 33
Wade, A. N., Maposa, I., Agongo, G., Asiki, G., Boua, P. R., Choma, S., Gómez-Olivé, F. X., Maimela, E., Micklesfield, L. K., Mohamed, S. F., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069193 · Cited by 31
Pitak, P., Tasai, S., Kumpat, N., Songkla, P. N., Fuangchan, A., Krass, I., & Dhippayom, T. (2023) · Public Health · doi:10.1016/j.puhe.2023.10.015 · Cited by 31
Hatada, M., Wilson, E. D., Khanwalker, M., Probst, D., Okuda‐Shimazaki, J., & Sode, K. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130914 · Cited by 27
Resurrección, D. M., Navas-Campaña, D., Gutiérrez-Colosía, M. R., Ibáñez-Alfonso, J. A., & Ruiz-Aranda, D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010940 · Cited by 31
Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines
Mohan, V., Saboo, B., Khader, J., Modi, K. D., Jindal, S., WANGNOO, S. K., & Sugumaran, A. (2022) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514221074663 · Cited by 35
Khanal, M. K., Bhandari, P., Dhungana, R. R., Gurung, Y., Rawal, L. B., Pandey, G., Bhandari, M., Devkota, S. P., de Courten, M., & de Courten, B. V. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271888 · Cited by 29
Martyn-Nemeth, P. A., Duffecy, J. L., Quinn, L., Steffen, A. D., Baron, K. G., Chapagai, S., Burke, L., & Reutrakul, S. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221136495 · Cited by 27
Early Post-Renal Transplant Hyperglycemia
Iqbal, A., Zhou, K., Kashyap, S. R., & Lansang, M. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab697 · Cited by 31
Nielsen, V. M., Song, G., Ojamaa, L. S., Blodgett, R. P., Rocchio, C., & Pennock, J. N. (2022) · Public Health Reports · doi:10.1177/00333549211065515 · Cited by 27
Woodard, L., Amspoker, A. B., Hundt, N. E., Gordon, H. S., Hertz, B., Odom, E., Utech, A. E., Razjouyan, J., Rajan, S. S., Kamdar, N. P., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.9975 · Cited by 34
Gao, X., Ma, X., Lin, P., Wang, Y., Zhao, Z., Zhang, R., Yu, B., & Hao, Y. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043084 · Cited by 24
Salinero-Fort, M. Á., Andrés-Rebollo, F. J. S., Cárdenas‐Valladolid, J., Méndez‐Bailón, M., Chico-Moraleja, R. M., Pau, E. C. D. S., Jiménez‐Trujillo, I., Gómez-Campelo, I., de Burgos‐Lunar, C., de Miguel-Yanes, J. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94121-8 · Cited by 25
dos Reis, R. C. P., Duncan, B. B., Szwarcwald, C. L., Malta, D. C., & Schmidt, M. I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153428 · Cited by 29
Frank, J., Blissett, D. B., Hellmund, R., & Virdi, N. S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0263 · Cited by 30
Bellido, V., & Pérez, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225341 · Cited by 31
Blaine, E., Tumlinson, R., Colvin, M., HAYNES, T. G., & Whitley, H. P. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2659 · Cited by 26
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
Ni, X., Zhang, L., Feng, X., & Tang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.877797 · Cited by 26
Christiansen, M. P., Cummins, M., Prestrelski, S., Close, N. C., Nguyen, A., & Junaidi, K. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002137 · Cited by 22
Wang, B., Sun, Y. B., Zhang, K., Wang, Y., Tan, X. W., Wang, N., & Lu, Y. (2024) · International Journal of Epidemiology · doi:10.1093/ije/dyae056 · Cited by 25
Lee, D. Y., Kim, J., Park, S. H., Park, S. Y., Yu, J. H., Seo, J. A., Kim, N. H., Yoo, H. J., Kim, S. G., Choi, K. M., et al. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0346 · Cited by 24
“However, as HbA1c levels indicate the average glucose status [42], FG levels are more suitable for estimating GV than HbA1c levels.”
Piccini, B., Pessina, B., Casalini, E., Lenzi, L., & Toni, S. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13440 · Cited by 24
Aihara, M., Jinnouchi, H., Yoshida, A., Ijima, H., Sakurai, Y., Hayashi, T., Koizumi, C., Kubota, T., Usami, S., Yamauchi, T., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110637 · Cited by 25
Zhang, Y., Song, Y., Lu, Y., Liu, T., & Yin, P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1517658 · Cited by 25
Addala, A., Zaharieva, D. P., Gu, A., Prahalad, P., Scheinker, D., Buckingham, B. A., Hood, K. K., & Maahs, D. M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab522 · Cited by 23
Çelik, S. G., Yılmaz, F. T., Çelik, S. Y., Anataca, G., & Bülbül, E. (2021) · Journal of Clinical Nursing · doi:10.1111/jocn.16088 · Cited by 21
Kompala, T., Wong, J. C., & Neinstein, A. B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221088267 · Cited by 28
Rydberg, M., Zimmerman, M., Gottsäter, A., Eeg‐Olofsson, K., & Dahlin, L. B. (2022) · Diabetes Care · doi:10.2337/dc22-0829 · Cited by 21
Geta, E. T., Terefa, D. R., Hailu, W. B., Olani, W., Merdassa, E., Dessalegn, M., Gelchu, M., & Diriba, D. C. (2024) · PLOS ONE · doi:10.1371/journal.pone.0306296 · Cited by 21
The frequency of intermittently scanned glucose and diurnal variation of glycemic metrics
Hansen, K. W., & Bibby, B. M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211019382 · Cited by 20
González-Álvarez, M. E., Riquelme-Aguado, V., González-Pérez, Á., Murillo-Llergo, R., Manjón-Olmedillas, M., Turroni, S., Rossettini, G., & Villafañe, J. H. (2024) · Cells · doi:10.3390/cells13201719 · Cited by 20
“Altered glucose metabolism may reduce the ability to manage postprandial glucose spikes, potentially leading to energy fluctuations and increased systemic inflammation [22].”
BackgroundCardiovascular Risk/Disease in Type 2 Diabetes Mellitus
Román, G., & Stoian, A. P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97422 · Cited by 30
Diabetes outcomes before and during telehealth advancements surrounding COVID-19
Woodhouse, A., Orvin, C., Rich, C., Crosby, J. F., & Keedy, C. A. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.09.011 · Cited by 22
Managing weight and glycaemic targets in people with type 2 diabetes—How far have we come?
Blüher, M., Ceriello, A., Davies, M., Rodbard, H., Sattar, N., Schnell, O., Tonchevska, E., & Giorgino, F. (2022) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.330 · Cited by 20
Banks, J., Amspoker, A. B., Vaughan, E. M., Woodard, L., & Naik, A. D. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.42950 · Cited by 21
Feng, X., Deng, M., Zhang, L., & Pan, Q. (2023) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2023-0116 · Cited by 23
“[16] Gastric emptying, intestinal proinsulin system, and preprandial blood glucose levels affect postprandial blood glucose levels.”
BackgroundHayek, A. A., Alsaeed, A. H., Alzahrani, W. M., & Dawish, M. A. A. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01126-7 · Cited by 24
Setting analytical performance specifications using HbA1c as a model measurand
Loh, T. P., Smith, A. F., Bell, K., Lord, S. J., Ceriotti, F., Jones, G. R. D., Bossuyt, P. M., Sandberg, S., & Horvath, A. R. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.10.016 · Cited by 21
Wang, J., Li, J., Wen, C., Liu, Y., & Ma, H. (2021) · Medicine · doi:10.1097/md.0000000000027677 · Cited by 19
Guevara, E., Torres‐Galván, J. C., González, F. J., Luévano‐Contreras, C., Castillo‐Martínez, C., & Ramírez‐Elías, M. G. (2022) · Journal of Biophotonics · doi:10.1002/jbio.202200055 · Cited by 20
Association of hemoglobin A1c time in range with risk for diabetes complications
Mohr, D. C., Zhang, L., Prentice, J. C., Nelson, R. E., Li, D., Pleasants, E. A., & Conlin, P. R. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002738 · Cited by 29
Végh, D., Bencze, B., Bányai, D., Vegh, A., Rózsa, N. K., Dobó‐Nagy, C., Biczó, Z., Kammerhofer, G., Ujpál, M., Agurto, L. D., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064745 · Cited by 28
Scarton, L. J., Nelson, T., Yao, Y., DeVaughan-Circles, A., Legaspi, A. B., Donahoo, W. T., Segal, R., Goins, R. T., Manson, S. M., & Wilkie, D. J. (2023) · Diabetes Care · doi:10.2337/dc22-1885 · Cited by 30
Issues and challenges in diabetic neuropathy management: A narrative review
Ismail, C. A. N. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.741 · Cited by 31
Takagi, S., Miura, J., Takita, M., Mochizuki, S., Asanuma, T., Hoshina, S., Takaike, H., Uchigata, Y., & Babazono, T. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13886 · Cited by 20
Ang, L. P., Kidwell, K., Dillon, B. R., Reiss, J., Fang, F., LEONE, V. A., Mizokami‐Stout, K., & Pop‐Busui, R. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107949 · Cited by 19
Impact of a Digitally Enhanced Diabetes Self-Management Program on Glycemia and Medical Costs
Chen, F., Jasik, C. B., Dall, T. M., & Siego, C. V. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221100779 · Cited by 20
Hafidh, K., Malek, R., Al-Rubeaan, K. A., Kok, A., Bayram, F., Echtay, A. S., Rajadhyaksha, V., & Hadaoui, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.940309 · Cited by 25
Cho, E., Jeong, T., Kim, S., Park, H., Yun, Y., Chun, S., & Min, W. (2023) · Annals of Laboratory Medicine · doi:10.3343/alm.2023.43.5.425 · Cited by 20
“We selected EQA samples with concentrations close to medical decision levels according to corresponding clinical guidelines and subsequently calculated the absolute percentage bias for each test item (Supplemental Data Table S1) [17–23].”
Felix dies natalis, insulin… ceterum autem censeo “beta is better”
Piemonti, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01737-3 · Cited by 19
Colberg, S. R., Kannane, J., & Diawara, N. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18179332 · Cited by 25
Liao, P.-Y., Lo, H., Liu, I.-C., Lo, L.-C., Hsiang, C., & Ho, T. (2022) · Food & Function · doi:10.1039/d1fo02788c · Cited by 19
Holmes-Truscott, E., Baptista, S., Ling, M., Collins, E., Ekinci, E. I., Furler, J., Hagger, V., Manski-Nankervis, J.-A., Wells, C., & Speight, J. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1177030 · Cited by 17
Prevalence and predictors of hypoglycemia in older outpatients with type 2 diabetes mellitus
Al‐Azayzih, A., Kanaan, R. J., Altawalbeh, S. M., Alzoubi, K. H., Kharaba, Z. J., & Jarab, A. S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309618 · Cited by 24
O’Donovan, A. J., Oser, S. M., Parascando, J. A., Berg, A. S., Nease, D. E., & Oser, T. K. (2021) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1819 · Cited by 18
Meral, R., Malandrino, N., Walter, M. F., Neidert, A., Muniyappa, R., Oral, E. A., & Brown, R. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab760 · Cited by 22
Barua, S., Sabharwal, A., GLANTZ, N. M., Conneely, C., LAREZ, A. J., Bevier, W. C., & Kerr, D. E. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101241 · Cited by 21
The Risk Factors of Severe Hypoglycemia in Older Patients with Dementia and Type 2 Diabetes Mellitus
Chen, N.-C., Chen, C., & Shen, F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010067 · Cited by 20
Boye, K. S., Lage, M. J., & Thieu, V. T. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01212-4 · Cited by 19
Rattanavipanon, W., Chaiyasothi, T., Puchsaka, P., Mungkornkaew, R., Nathisuwan, S., Veettil, S. K., & Chaiyakunapruk, N. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15279 · Cited by 30
Han, H., Lai, J., Yan, C., Li, X., Hu, S., He, Y., & Li, H. (2022) · BMC Surgery · doi:10.1186/s12893-022-01601-3 · Cited by 17
Belthangady, C., Giampanis, S., Jankovic, I., Stedden, W., Alves, P., Chong, S., Knott, C., & Norgeot, B. (2022) · Nature Communications · doi:10.1038/s41467-022-33732-9 · Cited by 17
U-shaped association between HbA1c and all-cause mortality in CVD patients with diabetes
Yu, J., Hua, H., & Yin, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-80116-8 · Cited by 17
Digital Solutions to Diagnose and Manage Postbariatric Hypoglycemia
Schönenberger, K. A., Cossu, L., Prendin, F., Cappon, G., Wu, J., Fuchs, K. L., Mayer, S., Herzig, D., Facchinetti, A., & Bally, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.855223 · Cited by 16
Diabetes Care in India: A Descriptive Study
Dixit, J. V., Kulkarni, R. S., & Badgujar, S. Y. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_260_21 · Cited by 16
Ballato, E., Deepika, F., Russo, V., Fleires-Gutierrez, A. L., Colleluori, G., Fuenmayor, V., Chen, R., Villareal, D. T., Qualls, C., & Armamento‐Villareal, R. (2022) · Calcified Tissue International · doi:10.1007/s00223-022-00993-x · Cited by 17
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-12-04
- Volume
- 44
- Issue
- Supplement_1
- Pages
- S73-S84
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4236126199
- Cited by
- 847
- References
- 118
- Citations by year
- 2026: 43 · 2025: 80 · 2024: 115 · 2023: 156 · 2022: 265 · 2021: 187 · 2020: 1
- FWCI
- 23.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, diabetes management, clinical guidelines, quality of care, level of evidence, treatment goals
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Endocrinology, Humans, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.